新型冠状病毒有关药物和生物制品研究进展

Advances in research of novel coronavirus related drugs and biological products

自2019年12月发现新型冠状病毒肺炎患者起,至2020年2月21日新冠病毒肺炎疫情已扩散至27个国家,全球患者总数近8万人。此次疫情受到世界各国广泛关注,为了有效应对疫情,各国正组织科研攻关,特别是在治疗药物筛选和疫苗研发等方面加大攻关力度,这是控制疫情的重点和难点。本文收集整理了各国学术界和政府关于药物和生物制品的相关研究信息,主要围绕可能用于治疗新型冠状病毒肺炎的化学药、中药和生物制品的研究情况,供有关部门、单位和科技人员参考。

The novel coronavirus pneumonia was first discovered in December 2019.By February 21,2020,the virus had spread to 27 countries,and the total number of patients were nearly 80 thousands.In order to effectively prevent and control the epidemic,countries around the world are organizing scientific research,especially in screening of therapeutic drugs,researching and developing of vaccine,which is the key point and difficulty of epidemic control.On the basis of a large number of relevantly collected information about drugs and biological products in the academia and the press of various countries,this paper focus on the research status and development of antiviral chemical drugs,Chinese traditional medicines and biological products,aiming to provide reference for relevant departments,units and scientists.